David Mehalick insider trades

Open-market stock purchases and sales by David Mehalick, CEO and President at Coeptis Therapeutics Holdings, Inc, from SEC Form 4 filings since Nov 16, 2021.

Recent trades

DateStockTradeValue
Feb 11, 2026COEP Coeptis Therapeutics Holdings, IncBought (not open market)—
Feb 11, 2026COEP Coeptis Therapeutics Holdings, IncBought (not open market)$1M

Companies traded

  • COEP Coeptis Therapeutics Holdings, Inc: 3 buys, 1 sale, last Feb 11, 2026

Get free alerts when David Mehalick files a new trade →